What is Flexiban, the joint‑support supplement marketed in Brazil, including its ingredients and recommended dosage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Flexiban: Informação sobre o Produto

Não há evidências científicas disponíveis sobre "Flexiban" como suplemento para articulações comercializado no Brasil nas bases de dados médicas revisadas.

Contexto Importante

A literatura médica fornecida não contém informações específicas sobre um produto chamado "Flexiban", seus ingredientes ou dosagem recomendada. As evidências disponíveis discutem:

  • Diretrizes para tratamento de osteoartrite 1
  • Medicamentos fitoterápicos brasileiros para osteoartrite 2, 3
  • Outros suplementos com nomes diferentes (FLEXA, Cyplexinol, Flexipill) que não são o mesmo produto 4, 5, 6

Armadilhas Comuns

É crucial não confundir "Flexiban" com outros produtos de nomes semelhantes:

  • FLEXA - formulação fitoterápica asiática contendo Ostericum koreanum, Cibotium barometz e Carthamus tinctorius 4
  • Cyplexinol® - complexo proteico de proteína morfogenética óssea (900 mg/dia) 6
  • Flexipill - combinação impressa em 3D para hipertensão, não relacionada a articulações 5

Recomendação Prática

Se você está procurando informações sobre um suplemento específico para articulações vendido no Brasil, solicite a bula ou rótulo do produto diretamente, pois "Flexiban" não aparece na literatura médica indexada. Para tratamento baseado em evidências de dor articular ou osteoartrite no Brasil, as diretrizes recomendam tratamentos centrais (exercício, perda de peso, educação) seguidos por AINEs tópicos como primeira linha farmacológica 1, 7.

A revisão sistemática de fitoterápicos orais brasileiros para osteoartrite encontrou evidências de baixa qualidade, insuficientes para recomendar a maioria desses produtos 3.

References

5
Research

Flexipill: A novel 3D printed flexible dose combination for hypertension with a floating element.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2025

6
Research

The dietary supplement Cyplexinol® alleviates joint pain in men and women.

Journal of clinical and translational research, 2023

Related Questions

In a man with ankylosing spondylitis whose symptoms are only partially relieved by nonsteroidal anti‑inflammatory drugs (NSAIDs) and who has normal laboratory work, what is the next step in treatment and evaluation?
What is the appropriate treatment and next steps for a 60-year-old patient with new-onset atrial fibrillation, a ventricular rate of 112 beats per minute (tachycardia), oxygen saturation 98% on room air, and a normal echocardiogram?
What is the recommended treatment for a partial tear of the proximal gastrocnemius tendon of the right leg and a grade 3 chondral fissure of the distal lateral femoral condyle?
Can ticagrelor (Brilinta) be prescribed together with enoxaparin (Lovenox)?
What is the recommended dose and safety considerations for cyclobenzaprine?
What is the incidence of tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in children receiving treatment for disseminated tuberculosis?
In a 35-year-old patient with BMI 32, blood pressure 138/88 mmHg, total cholesterol 232 mg/dL, HDL 34 mg/dL, LDL 125 mg/dL, triglycerides 342 mg/dL, normal A1c and creatinine, who already does 150 minutes of moderate physical activity per week, what is the next appropriate intervention—dietary modification or medication—according to guidelines?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.